Medicaid Coverage of Medication Assisted Treatment (MAT): A 50-state overview
Medication Assisted Treatment (MAT) refers to evidence based therapies used to treat diagnosed opioid dependence. The Centers for Disease Control and Prevention (CDC) has defined an epidemic of overdose deaths related to opioid pain relievers. The Health Resources and Services Administration (HRSA), along with the Substance Abuse and Mental Health Services Administration (SAMHSA) track current developments in this area, and provide a MAT overview and educational resources.
The states’ Medicaid programs vary widely in payment and coverage for MAT. The Kaiser Family Foundation has a comprehensive report using 2017 information and can be found here: Medicaid's Role in Addressing the Opioid Epidemic. The report highlights states’ coverage for various therapies, including coverage of Methadone, Buprenorphine, Naloxone, injectable Naltrexone, and counseling requirements.
Related NCSL Resources
Additional MAT Resources